BELLEAU et al. V. CHENG et al. - Page 2





                                                                                           Interference No. 104,396                     
                                                                                                               Page 2                   
                       Count 4. A method of treating hepatitis B virus infection and/or inhibiting hepatitis                            
                                       B virus replication in a patient in need thereof comprising: administering                       
                                       to said patient an effective amount of BCH-I 89 or a pharmaceutically                            
                                       acceptable salt, ester or salt of an ester thereof                                               
                       Count 5. A method of treating hepatitis B virus infection and/or inhibiting hepatitis                            
                                       B virus replication in a patient in need thereof comprising: administering                       
                                       to said patient a composition comprising an effective amount of (-)-cis-4                        
                                       amino- I -(2-hydroxymethyl- 1,3-oxathiolan-5-yl)-(l H)-pyrimidin-2-one or                        
                                       a pharmaceutically acceptable salt, ester or salt of an ester thereof, wherein                   
                                       the composition contains no more than about 5 weight percent of the                              
                                       corresponding (+) enantiomer, and wherein the weight percent is based on                         
                                       the total combined weight of the (-) and (+) enantiomers.                                        
               (Paper No. 233, p. 5 1). To aid the Board in redeclaring the interference, the parties were invited                      
               to provide proposed claim correspondences for the two new counts. Specifically, the parties                              
               were to jointly submit a statement of the claim correspondences upon which there was agreement                           
               and to provide comments regarding those claim correspondences for which no agreement could                               
               be reached.                                                                                                              
                       The parties currently pending claims are as f6flows:','                                                          






                       'As discussed in the Memorandum, Opinion and Order, Cheng's Renewed Proposed                                     
               Amendment (Paper No.'193) is to be entered into Cheng's involved U.S. Application                                        
               08/463,960. Additionally, Cheng's amendment canceling claim 224 and adding new claim 225                                 
               is to be entered into Cheng's involved '960 application. The "currently pending" claims reflect                          
               the status of the claims upon entry of these amendments.                                                                 
                       2 We note that upon entry of Cheng's Amendment to Cancel Dependent Claim 224, claims                             
               170, 171 and 172 will depend ftom canceled claim 224. Should Cheng seekfurther                                           
               prosecution of the '960 application, Cheng shall submit an amendment amending claims 170,                                
               171 and 172 to dependfrom new claim 225. For purposes of this Judgment, it is assumed that                               
               claims 170, 171 and 172 depend from new claim 225.                                                                       








Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007